Ultra-Sensitive Biosensors for Medical Applications Based on Nanomechanics: From Detection of Synthetic Biomolecules to Analysis of Sepsis in Pediatric Patients DOI Creative Commons
François Huber, H.P. Lang, Andrea Marten

et al.

Biosensors, Journal Year: 2025, Volume and Issue: 15(4), P. 217 - 217

Published: March 28, 2025

Recent advancements in nanomechanical microcantilever biosensors open new possibilities for clinical applications, permitting precise analysis of molecular interactions. The technology enables tracking gene expression, conformational changes, antibody binding and antibiotic resistance. In particular, hybridization DNA or RNA extracted from biopsies whole blood patients has led to significant diagnostics critical medical conditions, e.g., cancer, bacteraemia sepsis, utilizing rapid, sensitive, label-free detection. Direct diagnosis patient samples is a decisive advantage over competitive methods circumventing elaborate time-consuming purification, amplification cultivation procedures prior analysis. Here, recent developments are presented simple synthesized oligonucleotides material obtained patients’ samples, highlighting technological diagnostic such as detection pathogens disease biomarkers. We envisage our method be input early sensitive directly without requirements cultivation. This would represent paradigm shift diagnostics, no competing currently exists.

Language: Английский

Ultra-Sensitive Biosensors for Medical Applications Based on Nanomechanics: From Detection of Synthetic Biomolecules to Analysis of Sepsis in Pediatric Patients DOI Creative Commons
François Huber, H.P. Lang, Andrea Marten

et al.

Biosensors, Journal Year: 2025, Volume and Issue: 15(4), P. 217 - 217

Published: March 28, 2025

Recent advancements in nanomechanical microcantilever biosensors open new possibilities for clinical applications, permitting precise analysis of molecular interactions. The technology enables tracking gene expression, conformational changes, antibody binding and antibiotic resistance. In particular, hybridization DNA or RNA extracted from biopsies whole blood patients has led to significant diagnostics critical medical conditions, e.g., cancer, bacteraemia sepsis, utilizing rapid, sensitive, label-free detection. Direct diagnosis patient samples is a decisive advantage over competitive methods circumventing elaborate time-consuming purification, amplification cultivation procedures prior analysis. Here, recent developments are presented simple synthesized oligonucleotides material obtained patients’ samples, highlighting technological diagnostic such as detection pathogens disease biomarkers. We envisage our method be input early sensitive directly without requirements cultivation. This would represent paradigm shift diagnostics, no competing currently exists.

Language: Английский

Citations

0